Liver injury can be induced by a variety of factors, such as acetaminophen, viruses, and toxic substances. These factors cause damage to accumulate, which can lead to loss of liver function and affect vital body functions like brain, kidneys, and immu...
Liver injury can be induced by a variety of factors, such as acetaminophen, viruses, and toxic substances. These factors cause damage to accumulate, which can lead to loss of liver function and affect vital body functions like brain, kidneys, and immune system.
Lipopolysaccharide (LPS)-induced liver injury happens when LPS reaches at the liver because of intestinal membrane permeability, leading to increased oxidative stress and overproduction of reactive oxygen species (ROS) in hepatocytes, mainly due to stimulation of various signaling systems, including the NF-κB pathway.
DDIT4(DNA damage inducible transcript 4; REDD1) is a cellular stress-responsive protein whose expression is increased by hypoxia, DNA damage, reactive oxygen species, and ER stress. DDIT4 is known to regulate various cellular functions in several animal cells, primarily as an inhibitor of mammalian target of rapamycin(mTOR).
In this study, we aimed to figure out the role of DDIT4 in the LPS-induced liver injury disease model. We found that LPS treatment into AML12 cells, a hepatocyte cell line, and C57BL/6J mice increased DDIT4 expression and inflammatory response. We also established a hepatocyte-specific DDIT4 knockout model and found that DDIT4 knockout in hepatocytes suppressed LPS-induced liver injury and inflammatory marker expression. Primary hepatocyte isolation from hepatocyte-specific DDIT4 knockout mice was used to examine mitochondrial biosynthesis and found that ROS were significantly reduced. In conclusion, DDIT4 deficiency reduces LPS-induced liver injury, suggesting that inhibition of DDIT4 expression may be a therapeutic target for liver disease.